161 related articles for article (PubMed ID: 15233226)
1. Rationale for treating cancer with somatostatin analogs.
Minuto F; Ferone D; Arvigo M; Barreca A
J Endocrinol Invest; 2003; 26(8 Suppl):117-9. PubMed ID: 15233226
[No Abstract] [Full Text] [Related]
2. Antitumor effects of somatostatin.
Pyronnet S; Bousquet C; Najib S; Azar R; Laklai H; Susini C
Mol Cell Endocrinol; 2008 May; 286(1-2):230-7. PubMed ID: 18359151
[TBL] [Abstract][Full Text] [Related]
3. Role of somatostatin analogs in the management of rare tumors and diseases.
Palmieri G; Montella L
J Endocrinol Invest; 2003; 26(8 Suppl):89-91. PubMed ID: 15233221
[No Abstract] [Full Text] [Related]
4. Somatostatin receptors and breast cancer.
Cameron Smith M; Orlando C; Serio M; Maggi M
J Endocrinol Invest; 2003; 26(8 Suppl):125-30. PubMed ID: 15233228
[No Abstract] [Full Text] [Related]
5. The effects of somatostatin analogs on biochemical parameters in acromegaly.
Liuzzi A; Marzullo P
J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
[No Abstract] [Full Text] [Related]
6. The role of somatostatin analogs in the management of prostate cancer.
Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D
J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227
[No Abstract] [Full Text] [Related]
7. The role of somatostatin analogs in the control of tumor growth.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):61-4. PubMed ID: 7992085
[No Abstract] [Full Text] [Related]
8. The role of somatostatin analogs in the management of immunoproliferative disease.
Ferone D; Arvigo M; Semino C; Pivonello R; van Hagen PM; Barreca A; Minuto F
J Endocrinol Invest; 2003; 26(8 Suppl):103-8. PubMed ID: 15233223
[No Abstract] [Full Text] [Related]
9. Conclusions: the future role of somatostatin analogs.
Lamberts SW
J Endocrinol Invest; 2003; 26(8 Suppl):134-5. PubMed ID: 15233230
[No Abstract] [Full Text] [Related]
10. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
11. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly.
Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E
J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214
[No Abstract] [Full Text] [Related]
12. Chemotherapy targeted to cancers through tumoral hormone receptors.
Schally AV; Nagy A
Trends Endocrinol Metab; 2004 Sep; 15(7):300-10. PubMed ID: 15350601
[TBL] [Abstract][Full Text] [Related]
13. Biology of somatostatin in breast cancer.
Watt HL; Kharmate G; Kumar U
Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
15. Editorial: somatostatin receptor-based scintigraphy and antitumor treatment--an expanding vista?
Jensen RT
J Clin Endocrinol Metab; 2000 Oct; 85(10):3507-8. PubMed ID: 11061490
[No Abstract] [Full Text] [Related]
16. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors.
Kvols LK; Woltering EA
Anticancer Drugs; 2006 Jul; 17(6):601-8. PubMed ID: 16917205
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog.
Hofland LJ
J Endocrinol Invest; 2003; 26(8 Suppl):8-13. PubMed ID: 15233204
[No Abstract] [Full Text] [Related]
18. Management of breast cancer: is there a role for somatostatin and its analogs?
Boccardo F; Amoroso D
Chemotherapy; 2001; 47 Suppl 2():62-77. PubMed ID: 11275703
[TBL] [Abstract][Full Text] [Related]
19. The role of somatostatin analogs in the management of hepatocellular carcinoma.
D'Agostino L; Manguso F; Pivonello R; Colao A
J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229
[No Abstract] [Full Text] [Related]
20. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
Pivonello R; Ferone D; Filippella M; Faggiano A; De Martino MC; Auriemma RS; Rota F; Lombardi G; Colao A
J Endocrinol Invest; 2003; 26(8 Suppl):82-8. PubMed ID: 15233220
[No Abstract] [Full Text] [Related]
[Next] [New Search]